Absoluetly, confirmed significant reduction in NfL , confirmed reduction in iron levels, confirmed brain mass loss stabilisation, confirmed mitochodrial protection...incredibly hard to see we wont smash the 201 study and get FDA approval, plus extension into other studies.
I will continue to make purchases for this stock, 7wks unyil the 201 study is complete.
Does anyone know if those in the 202 study are still taking ATH434 post their 12mnth completion ?
Ann: Alterity Presents Data Describing Neuroprotection of ATH434, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.5¢ | $787.6K | 48.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 9250665 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 6931087 | 13 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |